Skip to content

The role of biased µ-opioid receptor agonists in postoperative pain management for obstetrical patients

The role of biased µ-opioid receptor agonists in postoperative pain management for obstetrical patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100326
Enrollment
Unknown
Registered
2025-04-08
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after cesarean section

Interventions

Control group:100ug sufentanil citrate was prepared into a 100ml solution using 0.9% sodium chloride injection, a loading dose of 6ug (6ml) was given for the first pain after giving birth, and a PCA d
Treatment group:25mg TRV130 was prepared into a 100ml solution with 0.9% sodium chloride injection, a loading dose of 1.5mg (6ml) was given for the first pain after delivery, and a PCA dose could be u

Sponsors

Lianyungang First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Age 20-45 years (including the critical value); 2.Preoperative American Society of Anesthesiologists (ASA) Grade II to III; 3.Patients undergoing cesarean section under intravertebral anesthesia; 4.Subjects voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients allergic to any drugs used in the study; 2.Patients with a history of chronic pain or long-term use of sedative analgesics; 3.Patients with a history of mental illness or long-term use of psychotropic drugs; 4.Patients with abnormal liver and kidney function; 5.Patients with severe pregnancy complications, such as preeclampsia, placental hyperplasia spectrum, or HELLP syndrome; 6.Patients who are unable to understand and correctly express VAS pain scores; 7.Patients who have participated in other clinical studies within the last 3 months.

Design outcomes

Primary

MeasureTime frame
The total pain intensity was poor from 0 to 48 hours after surgery;

Secondary

MeasureTime frame
The sum of pain intensity differences at 12h, 24h, and 36h;The total number of compressions, the number of effective compressions and the total compression dose of the PCA pump during the 48-hour period;The time of first administration of remedial medication;The proportion of subjects using remedial drugs;The frequency and dosage of using remedial drugs;The proportion of subjects whose treatment failed due to insufficient analgesic effect;The satisfaction scores given by the investigators and the subjects regarding the analgesic treatment were evaluated 48 hours after administration.;

Countries

China

Contacts

Public ContactZhang Xiaobao

Lianyungang First People's Hospital

hotdog100@163.com+86 189 6132 2507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026